Smoking habit and comorbidity in patients with chronic obstructive pulmonary disease

Authors

Keywords:

COPD, comorbidity, phenotype, smoking habit.

Abstract

Introduction: Chronic obstructive pulmonary disease constitutes a health problem in Cuba and the world, its prognosis is related to several factors.
Objective: To characterize a series of hospitalized patients with chronic obstructive pulmonary disease, according to age, sex, phenotype, smoking habit and comorbid diseases.
Method: A descriptive cross-sectional study was carried out that included the 296 patients who were admitted to the Internal Medicine Service of the Central Military Hospital "Dr. Carlos J. Finlay" with the diagnosis of chronic obstructive pulmonary disease in the period of two years. Comorbid diseases were determined, the phenotype given by the clinical presentation of the patients (A, B, C and D) ; age, sex, smoking habit or not, time and amount of smoking. The Charlson comorbidity index was used to assess the associated comorbidity in COPD.
Results: 54 % of the patients were male, 96,9 % older than 50 years, 36,1 % phenotype C, and 76,6 % smokers. Hypertension was more frequent in phenotypes B, C and D, in more than 70 %, diabetes mellitus in 73,7 % of phenotype B, and ischemic heart disease in 61,7 % of phenotype D.
Conclusions: Most of the patients studied were male, older than 50 years, smokers for more than 10 years and phenotype C. The most frequent comorbid diseases were arterial hypertension, diabetes mellitus and ischemic heart disease.

Downloads

Download data is not yet available.

Author Biography

Luis Alberto Bestard Pavón, Hospital Dr. Carlos J. Finaly

Especialista Primer Grado Medicina Interna

References

1. OPS. Informe sobre Control de Tabaco para la Región de las Américas. Washington DC: OPS/OMS; 2016[acceso: 05/11/2020]. Disponible en: https://iris.paho.org/bitstream/handle/10665.2/28380/9789275318867_spa.pdf

2. Legrá AN, Toledano GPY, Riverón PI, Del Campo MM, Silvera DS. Caracterización clínico epidemiológica de pacientes con enfermedad pulmonar obstructiva crónica MEDISAN. 2014[acceso: 05/11/2020]; 18(9):1274. Disponible en: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192014000900013

3. Iglesias Becoña E. Trastornos relacionados con sustancias y trastornos adictivos. C Med Psicosom. 2014[acceso: 05/11/2020];110: 58-61. Disponible en: https://dialnet.unirioja.es/descarga/articulo/4803011.pdf

4. Benet M, Espinosa A, Morejón A, Diez E, Landrove O, Ordúñez P. La prevalencia de tabaquismo en la ciudad de Cienfuegos, Cuba. MEDICC Review. 2014[acceso: 05/11/2020]; 16(3-4): Disponible en https://mediccreview.medicc.org/articles/mr_481_es.pdf

5. González J, Marín M, Sánchez-Salcedo P, Zulueta JJ. Lung cancer screening in patients with chronic obstructive pulmonary disease. Ann Transl Med. 2016[acceso: 05/11/2020]; 4(8):160. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860483/

6. OPS. Informe sobre Control de Tabaco para la Región de las Américas. A los 10 años del convenio Marco de la Organización Mundial de la Salud para el control del tabaco. Washington DC: OPS/OMS; 2016[acceso: 05/11/2020]. Disponible en: https://iris.paho.org/xmlui/bitstream/handle/123456789/28380/97892753188-67_spa.pdf

7. Albiol Chiva J. EPOC y Tabaquismo. [Trabajo de fin de grado]. Madrid: Universidad Complutense; 2015[acceso: 05/11/2020]. Disponible en: https://eprints.ucm.es/47799/1/ALBIOL%20CHIVA%2C%20JAUME.pdf

8. Noé DV, García GL, Sansores H, Ramírez VA. Impacto del tabaquismo y la EPOC sobre el funcionamiento cerebral. Neumol Cir Torax. 2014[acceso: 05/11/2020]; 73(3):196-204. Disponible en: https://www.medigraphic.com/pdfs/neumo/nt-2014/nt143h.pdf

9. Burkhardt R, Pankow W. The Diagnosis of Chronic Obstructive Pulmonary Disease. Dtsch Arztebl Int. 2014[acceso: 05/11/2020]; 111(49):834-46. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284520/

10. Hong Y, Lim MN, Kim WJ, Rhee CK, Yoo KH, Lee JH, et al. Influence of Environmental Exposures on Patients with Chronic Obstructive Pulmonary Disease in Korea. Tuberc Respir Dis (Seoul). 2014[acceso: 05/11/2020];76(5):226-32. Disponible en: https://pubmed.ncbi.nlm.nih.gov/24920949/

11. Fabbri LM. Smoking, not COPD, as the disease. N Engl J Med. 2016[acceso: 05/11/2020]; 374(19):1885-6. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27168438/

12. Cortés DP, López SB. Tabaquismo pasivo en el hogar: una invitación a la reflexión. Rev Clín Med Fam. 2014[acceso: 05/11/2020]; 7(3):234-7. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1699-695X2014000300010

13. Jiménez RCA, Solano RS, Signes CJ, De Higes ME, Granda OJI, Lorza BJJ, et al. Budgetary impact analysis on funding smoking cessation drugs in patients with COPD in Spain. Int J Chron Obstruct Pulmon Dis. 2015[acceso: 05/11/2020]; 10:2027-36. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590338/

14. De la Iglesia Martínez F, Serrano Arreba J, Montes Santiago J. Enfermedad obstructiva crónica (EPOC) y comorbilidades. Galicia Clin. 2012[acceso: 05/11/2020]; 73(Supl.1):S30-S36. Disponible en: https://galiciaclinica.info/PDF/17/310.pdf

15. Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008[acceso: 05/11/2020]; 5(4):549-55. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2645334/

16. Regan EA, Lynch DA, Curran-Everett D, Curtis JL, Austin JHM, Grenier PA, et al. Clinical and radiologic disease in smokers with normal spirometry. JAMA Intern Med. 2015[acceso: 05/11/2020]; 175(9):1539-49. Disponible en: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2323415

17. Franssen FM, Soriano JB, Roche N, Bloomfield PH, Brusselle G, Fabbri LM, et al. Lung function abnormalities in smokers with ischemic heart disease. Am J Respir Crit Care Med. 2016[acceso: 05/11/2020];194(5):568-76. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27442601/

Downloads

Published

2021-05-04

How to Cite

1.
Suárez Rivero B, Bestard Pavón LA, Cardosa García D, Rosell Suárez A, Barrero Viera L. Smoking habit and comorbidity in patients with chronic obstructive pulmonary disease. Rev Cubana Med Milit [Internet]. 2021 May 4 [cited 2025 Apr. 12];50(2):e0210984. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/984

Issue

Vol. 50 No. 2 (2021): April - June

Section

Research Article

License

Authors who have publications with this Journal accept the following terms:

  • The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
  • The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
  • Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.